Haleon PLC (LON:HLN)
348p+0.03%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Trusted health brands and strong cash flow support the thesis; North America recovery is the key test.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - Specialty & Generic
- Market Cap:
- £30.7B
Recent dividends
- 9 Apr 20264.90p
- 14 Aug 20252.20p
- 24 Apr 20254.60p
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Haleon PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free